{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:54:08Z","timestamp":1792641248545,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1053\/j.seminhematol.2004.07.009","type":"journal-article","created":{"date-parts":[[2005,11,3]],"date-time":"2005-11-03T08:58:14Z","timestamp":1131008294000},"page":"4-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":325,"special_numbering":"S5","title":["Therapeutic goals in the treatment of Gaucher disease"],"prefix":"10.1053","volume":"41","author":[{"given":"Gregory M.","family":"Pastores","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal J.","family":"Weinreb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Generoso","family":"Andria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Grabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod K.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tylki-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2004.07.009_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib2","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3635","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib3","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","article-title":"Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease","volume":"66","author":"Koprivica","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.nbd.2003.08.016","article-title":"Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells","volume":"14","author":"Schueler","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib5","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2106\/00004623-200105000-00016","article-title":"Gaucher disease. New approaches to an ancient disease","volume":"83-A","author":"Mankin","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1005655031239","article-title":"The natural course of Gaucher disease in The Netherlands","volume":"23","author":"Maaswinkel-Mooij","year":"2000","journal-title":"J Inherit Metab Dis"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib7","series-title":"Gaucher Disease","first-page":"177","article-title":"The pathology of Gaucher disease","author":"Lee","year":"1982"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/hch036","article-title":"Twin pairs showing discordance of phenotype in adult Gaucher\u2019s disease","volume":"97","author":"Lachmann","year":"2004","journal-title":"Q J Med"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1,028 patients with type 1 Gaucher disease after 2\u20135 years of treatment","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1023\/A:1025902113005","article-title":"The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease","volume":"26","author":"Cox","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib11","series-title":"Package insert, 2003","article-title":"Zavesca\u00ae (miglustat)","year":"2003"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1096-7192(02)00122-1","article-title":"Pulmonary hypertension in type 1 Gaucher\u2019s disease","volume":"77","author":"Mistry","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib13","first-page":"619","article-title":"[Clinical characteristics of type I Gaucher\u2019s disease in Spain. Preliminary results of national survey. Spanish Group on Gaucher\u2019s Disease]","volume":"109","author":"Giraldo","year":"1997","journal-title":"Med Clin (Barc)"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib14","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib15","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0950-3536(97)80034-0","article-title":"Plasma and metabolic abnormalities in Gaucher\u2019s disease","volume":"10","author":"Aerts","year":"1997","journal-title":"Baillieres Clin Haematol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<103::AID-AJH5>3.0.CO;2-V","article-title":"Platelet function abnormalities in Gaucher disease patients","volume":"61","author":"Gillis","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11926-000-0059-x","article-title":"Bone and joint complications related to Gaucher disease","volume":"2","author":"Pastores","year":"2000","journal-title":"Curr Rheumatol Rep"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib18","first-page":"603","article-title":"The surgical management of Gaucher\u2019s disease","volume":"95","author":"Aufses","year":"1982","journal-title":"Prog Clin Biol Res"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib19","first-page":"485a","article-title":"Massive and partially refractory splenomegaly significantly influences the platelet response to enzyme replacement therapy in thrombocytopenic patients with Gaucher disease","volume":"100","author":"Weinreb","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(98)90023-6","article-title":"Enzyme therapy for Gaucher disease","volume":"12","author":"Grabowski","year":"1998","journal-title":"Blood Rev"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib21","unstructured":"Gaucher Registry, 2004. Available at: http:\/\/www.lsdregistry.net\/gaucherregistry"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher\u2019s disease","volume":"93","author":"Lachmann","year":"2000","journal-title":"Q J Med"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1148\/radiology.160.3.3526400","article-title":"Gaucher disease","volume":"160","author":"Hill","year":"1986","journal-title":"Radiology"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2004.07.009_bib24","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/00005792-198509000-00003","article-title":"Skeletal complications of Gaucher disease","volume":"64","author":"Stowens","year":"1985","journal-title":"Medicine"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1542\/peds.96.4.629","article-title":"Enzyme replacement therapy for Gaucher disease","volume":"96","author":"Rosenthal","year":"1995","journal-title":"Pediatrics"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2004.07.009_bib27","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1259\/bjr.75.suppl_1.750025","article-title":"Response of Gaucher bone disease to enzyme replacement therapy","volume":"75","author":"Poll","year":"2002","journal-title":"Br J Radiol"},{"issue":"suppl 1","key":"10.1053\/j.seminhematol.2004.07.009_bib28","doi-asserted-by":"crossref","first-page":"A37","DOI":"10.1259\/bjr.75.suppl_1.750037","article-title":"Bone complications in children with Gaucher disease","volume":"75","author":"Bembi","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.genom.4.070802.110415","article-title":"Enzyme therapy for lysosomal storage disease","volume":"4","author":"Grabowski","year":"2003","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib30","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2003-11-3854","article-title":"Gaucher disease","author":"Wenstrup","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib31","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s002560000276","article-title":"Bone marrow response in treated patients with Gaucher disease","volume":"29","author":"Terk","year":"2000","journal-title":"Skeletal Radiol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1006\/bcmd.2001.0474","article-title":"Dixon quantitative chemical shift imaging is a sensitive tool for the evaluation of bone marrow responses to individualised doses of enzyme supplementation therapy in type 1 Gaucher disease","volume":"27","author":"Hollak","year":"2001","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib33","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s002560100375","article-title":"Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy","volume":"30","author":"Poll","year":"2001","journal-title":"Skeletal Radiol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib34","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/bcmd.2002.0511","article-title":"Correlation of bone marrow response with hematological, biochemical, and visceral responses to enzyme replacement therapy of non-neuronopathic (type 1) Gaucher disease in 30 adult patients","volume":"28","author":"Poll","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib35","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2292020296","article-title":"Quantification of bone involvement in Gaucher disease","volume":"229","author":"Maas","year":"2003","journal-title":"Radiology"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib36","first-page":"565","article-title":"Adult-type Gaucher disease in children","volume":"86","author":"Zevin","year":"1993","journal-title":"Q J Med"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-3476(96)70203-2","article-title":"Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase","volume":"129","author":"Kaplan","year":"1996","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib38","first-page":"158","article-title":"Delayed growth and puberty in patients with Gaucher disease type 1","volume":"2","author":"Kauli","year":"2000","journal-title":"Isr Med Assoc J"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib39","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/archinte.158.16.1754","article-title":"Gaucher disease","volume":"158","author":"Charrow","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/PL00008411","article-title":"Effects of enzyme replacement therapy in thirteen Japanese paediatric patients with Gaucher disease","volume":"160","author":"Ida","year":"2001","journal-title":"Eur J Pediatr"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.7326\/0003-4819-125-11-199612010-00005","article-title":"Pulmonary hypertension developing after alglucerase therapy in two patients with type 1 Gaucher disease complicated by the hepatopulmonary syndrome","volume":"125","author":"Dawson","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000203562","article-title":"Pulmonary hypertension in two patients with type I Gaucher disease while on alglucerase therapy","volume":"98","author":"Harats","year":"1997","journal-title":"Acta Haematol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib43","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(98)10194-0","article-title":"Echocardiographic assessment of pulmonary hypertension in Gaucher\u2019s disease","volume":"351","author":"Elstein","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib44","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood.V82.2.408.408","article-title":"Enzyme therapy in Gaucher disease type 1","volume":"82","author":"Pastores","year":"1993","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib45","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1015680827730","article-title":"Failure of resting echocardiography and cardiac catheterization to identify pulmonary hypertension in two patients with type I Gaucher disease","volume":"25","author":"Sirrs","year":"2002","journal-title":"J Inherit Metab Dis"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1023\/A:1008814105603","article-title":"The health-related quality of life of adults with Gaucher\u2019s disease receiving enzyme replacement therapy","volume":"7","author":"Damiano","year":"1998","journal-title":"Qual Life Res"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1023\/B:BOLI.0000005623.60471.51","article-title":"A neurological symptom survey of patients with type I Gaucher disease","volume":"26","author":"Pastores","year":"2003","journal-title":"J Inherit Metab Dis"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher disease with parkinsonian manifestations","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol Genet Metab"},{"issue":"suppl 2","key":"10.1053\/j.seminhematol.2004.07.009_bib49","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1012492429191","article-title":"Clinically relevant therapeutic endpoints in type I Gaucher disease","volume":"24","author":"Hollak","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1006\/bcmd.1999.0237","article-title":"T cell numbers relate to bone involvement in Gaucher disease","volume":"25","author":"Lacerda","year":"1999","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib51","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1006\/mgme.2001.3269","article-title":"Correlation among genotype, phenotype, and biochemical markers in Gaucher disease","volume":"75","author":"Whitfield","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease","volume":"103","author":"Boot","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib53","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1023\/A:1002849420541","article-title":"Chitotriosidase as a marker of macrophage stimulation","volume":"130","author":"Korolenko","year":"2000","journal-title":"Bull Exp Biol Med"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib54","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib55","first-page":"977","article-title":"Chitotriosidase genotype and plasma activity in patients with type 1 Gaucher disease and their relatives (carriers and non carriers)","volume":"86","author":"Giraldo","year":"2001","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib56","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0009-9120(99)00098-3","article-title":"Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease","volume":"33","author":"Czartoryska","year":"2000","journal-title":"Clin Biochem"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib57","unstructured":"Genzyme Corporation, Cambridge, MA. Data on file"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib58","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1046\/j.1365-2141.2000.02177.x","article-title":"Withdrawal of enzyme replacement therapy in Gaucher\u2019s disease","volume":"110","author":"Elstein","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib59","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1046\/j.1365-2141.2001.02821-13.x","article-title":"Effects of imiglucerase withdrawal on an adult with Gaucher disease","volume":"113","author":"Schwartz","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib60","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1046\/j.1365-2141.2001.02821-9.x","article-title":"Clinical monitoring after cessation of enzyme replacement therapy in M","volume":"113","author":"vom Dahl","year":"2001","journal-title":"Gaucher. Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib61","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1046\/j.1365-2141.2001.02821-11.x","article-title":"Interruption in enzyme replacement therapy for Gaucher disease","volume":"113","author":"Weinreb","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib62","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1034\/j.1600-0609.2003.00010.x","article-title":"Rebound hepatosplenomegaly in type 1 Gaucher disease","volume":"70","author":"Toth","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib63","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00125817-200211000-00005","article-title":"Cessation of enzyme replacement therapy in Gaucher disease","volume":"4","author":"Grinzaid","year":"2002","journal-title":"Genet Med"},{"key":"10.1053\/j.seminhematol.2004.07.009_bib64","series-title":"SF-36 Health Survey Manual and Interpretation Guide","author":"Ware","year":"1993"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304001325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196304001325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:14:59Z","timestamp":1758521699000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196304001325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":64,"alternative-id":["S0037196304001325"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.07.009","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic goals in the treatment of Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2004.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}